Efficacy and Safety of BG2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids.

Clinical trial NCT05620355 · UNKNOWN

Trial details

NCT number: NCT05620355
Sponsor: Bio Genuine (Shanghai) Biotech Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Uterine Fibroids Heavy Menstrual Bleeding

Start date: 2022-12-16
Primary completion: 2024-05-01
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.